Work

Supplementary Figure S7 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy

Year: 2024

Type: supplementary-materials

Abstract: Supplementary Figure S7. Manufacturing of Allo-T cells which are pre-primed alloreactive ‘recipient’ cells that recognize and kill ‘donor’ cells. A, Manufacturing timeline for the generation of Allo-T. B, CD30 expression of CD30KO Allo-T cells determined by the staining of CD30 with two different antibody clones, BY88 and BerH8, and flow cytometry analysis.

DOI: 10.1158/2326-6066.26422769.v1

Authors: Pei Y. Teo, Youngrock Jung, David H. Quach, Joanna Koh, Richard W. Ong, Angeline Goh, Alrina Tan, Chee H. Ng, Cheah C. Seh, Kar W. Tan, Ivan D. Horak, Lionel Low

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4401208409

Cites:

Cited by:

Related to: 10